Palleiko Benjamin L

Chief Executive Officer | CFO, Cbo | President, CFO, Cbo &Sec'y +3 more

1 company

Average

Trades Analyzed

12M Win Rate

15.8%

Avg 3M Return

-4.4%

Avg 12M Return

-34.7%

Palleiko Benjamin L is a Chief Executive Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $12.5M based on current market prices.

Holdings by Company

KALVApr 17, 2026

Current Shares462.6K

Value$12.49M

Net Activity-330,210

Bought: 0Sold: 330.2K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 20, 2024	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo	Sale+OE	22,802	$14.11	$321,845.67	-10.9%	-13.9%	-22.4%
Feb 14, 2024	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo	Sell	40,855	$15.01	$613,204.95	-20.4%	-13.3%	-33.8%
Nov 20, 2023	KALV Kalvista Pharmaceuticals, Inc.	President, CFO, Cbo &Sec'y	Sale+OE	13,008	$8.23	$107,046.73	-10.4%	+68.1%	+10.2%
Aug 18, 2023	KALV Kalvista Pharmaceuticals, Inc.	President, CFO, Cbo &Sec'y	Sale+OE	13,067	$10.73	$140,191.92	-12.1%	-29.4%	+11.3%
May 18, 2023	KALV Kalvista Pharmaceuticals, Inc.	President, CFO, Cbo &Sec'y	Sale+OE	4,037	$10.14	$40,952.94	-4.9%	+3.7%	+14.6%
Feb 17, 2023	KALV Kalvista Pharmaceuticals, Inc.	President, CFO, Cbo &Sec'y	Sale+OE	4,954	$7.66	$37,947.64	-6.4%	+28.1%	+83.0%
Nov 18, 2022	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo &Secretary	Sale+OE	722	$5.44	$3,927.68	-1.0%	+49.7%	+59.5%
Aug 17, 2022	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo &Secretary	Sale+OE	725	$14.96	$10,846.58	-1.1%	-65.7%	-28.1%
Feb 23, 2021	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo &Secretary	Sale+OE	29,642	$33.59	$995,561.82	-9.1%	-	-
Dec 30, 2020	KALV Kalvista Pharmaceuticals, Inc.	CFO, Cbo &Secretary	Sale+OE	358	$20.04	$7,174.79	-1.1%	-	-